Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome
about
The Role of PPARs in CancerPPARdelta regulates glucose metabolism and insulin sensitivityPPAR delta: a dagger in the heart of the metabolic syndrome.The role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionGene knockout of Acc2 has little effect on body weight, fat mass, or food intakeMetabolic shifts due to long-term caloric restriction revealed in nonhuman primatesRegulation of muscle fiber type and running endurance by PPARdeltaGene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoformsTranscriptional repression of mitochondrial function in aging: a novel role for the silencing mediator of retinoid and thyroid hormone receptors co-repressorAngiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubesCoordinate regulation of lipid metabolism by novel nuclear receptor partnershipsScaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentSulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacyTherapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Metabolic benefits of resistance training and fast glycolytic skeletal muscle.Prostaglandins and cancerDistinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivationScaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsEffects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARsThe PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cellsNuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophyPPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunctionAn ethanol extract of Artemisia iwayomogi activates PPARδ leading to activation of fatty acid oxidation in skeletal musclePostnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant miceAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivityPPARs and the complex journey to obesityPPARδ Promotes Running Endurance by Preserving GlucosePPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?Proteomic signature of muscle fibre hyperplasia in response to faba bean intake in grass carp.Nuclear receptors as drug targets for metabolic disease.Prolonged exposure to insulin suppresses mitochondrial production in primary hepatocytesResearch resource: nuclear hormone receptor expression in the endocrine pancreasPPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosisIL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ, SIRT1, PGC-1α, and PGC-1β expression in male mice.Haplotypes of the porcine peroxisome proliferator-activated receptor delta gene are associated with backfat thickness.Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterolDiet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle.Nuclear receptors, mitochondria and lipid metabolism
P2860
Q21342955-C613A42A-A8C2-4488-8F4A-F7060A2C5C92Q24541495-01D674C2-460B-44A9-93AE-206A07678AC2Q24541527-B0EF50B1-34DE-49F5-9B25-7ABD20466748Q24601222-9D2C8AC3-AF20-45C2-8752-409C36DDEFC3Q24622227-F358E320-0A7D-4F8F-9C09-865E6B3FA8FAQ24647414-DD7751CF-18B7-4203-885B-D930A3ED82A9Q24799428-469DB2BA-30ED-40D1-A16B-9C35D7E4F702Q24815580-2DF8AFF2-AFF7-4F00-8A97-03B76BDC709EQ26992046-F65B8633-C064-4B53-8836-E80BC90608D1Q27316586-BD60876E-65CC-4EB9-8FC5-DAC1C5BDB2D6Q27334219-894B971D-BEAD-43E9-84B0-D99F13B37911Q27653305-56502D91-87A2-403E-AE52-E167B669336FQ27666968-FE5E1E4D-8998-4CCF-9182-68E956E9E8BCQ27687166-D3059B7C-89B6-4078-B69D-23EAEDC43290Q27687459-BE1C88AE-95DB-48BB-A076-8A0D3B759D0FQ28188827-B6674B36-8B8A-47DA-A9DD-FBB0B6708144Q28299905-ECEEF861-5989-44AD-8D80-BAE48DBFA3B4Q28484657-99FABAE8-3727-40E3-8860-0D26E7421B5CQ28567700-86F226F1-0ACD-4C5D-A385-14B4F06CB943Q28569006-238EDFD2-7C33-47EC-80DE-C4A5B30D849CQ28570494-55A6CF17-0CB9-492C-972A-0969BAC7CD60Q28574319-01CFC5C7-D0C9-4B14-90A7-CD569EB70BB4Q28730913-1FDA5ED8-B476-48EB-A975-FD28E5EA6563Q28751044-A612443D-53CE-48C7-9946-6FA262884C87Q29614241-6CC03309-49BD-40C2-AB4F-91A7ADA3F11DQ29619271-7FDCCF43-6642-47D6-B9B7-03D85635C73AQ29792135-DAC7947E-8112-49B9-994E-5FB1C6FD1333Q30241952-C6E84B1C-F976-4117-921D-6393CF860B2AQ30353176-13381CD3-2AF2-43C5-8B74-9AF964EC32F4Q30377755-A6C87577-71B7-4AA9-B571-8D9859F60FD1Q30430126-64EA3391-83BD-410D-BA49-503AB436DE58Q30436106-4AC1B3A6-5562-4F4F-B973-23CB4C2A237EQ30438376-C24ED7C4-46BF-4C08-88B5-841A198A4757Q30482025-A827834D-9F99-41F5-BFC1-6F54868B3A0CQ30530614-342B0419-4680-4E91-B8CF-A6F068163F1EQ30924716-581AC8CA-D989-4131-A979-2A13E715BF4CQ33294481-75B07097-F526-416F-8F11-CB2B4CDCB545Q33660599-21EC0C69-09D9-40D1-B17D-7A00093D36E5Q33683551-836508DB-CAB8-46ED-B768-EB746A88AFCBQ33699001-86DF48FB-FECF-4BEC-8EB1-48356C3F9C2F
P2860
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome
description
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2003
@ast
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/12/23)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/12/23)
@nl
наукова стаття, опублікована в грудні 2003
@uk
name
Activation of peroxisome proli ...... attenuates metabolic syndrome
@ast
Activation of peroxisome proli ...... attenuates metabolic syndrome
@en
Activation of peroxisome proli ...... attenuates metabolic syndrome
@nl
type
label
Activation of peroxisome proli ...... attenuates metabolic syndrome
@ast
Activation of peroxisome proli ...... attenuates metabolic syndrome
@en
Activation of peroxisome proli ...... attenuates metabolic syndrome
@nl
prefLabel
Activation of peroxisome proli ...... attenuates metabolic syndrome
@ast
Activation of peroxisome proli ...... attenuates metabolic syndrome
@en
Activation of peroxisome proli ...... attenuates metabolic syndrome
@nl
P2093
P2860
P921
P356
P1476
Activation of peroxisome proli ...... attenuates metabolic syndrome
@en
P2093
Haruhisa Iguchi
Hiroki Hamura
Hiroshi Asaba
Johan Auwerx
Joji Yamamoto
Keisuke Tachibana
Kenta Magoori
Koichi Sumi
Makoto Naito
Masashi Yanagisawa
P2860
P304
15924-15929
P356
10.1073/PNAS.0306981100
P407
P577
2003-12-15T00:00:00Z